
Affordable PCR-quality test system. Without compromising on speed and accuracy.
Uh-Oh Labs provide healthcare providers with a Covid Test system that produces results in as fast as 12 mins with 96% accuracy — all for a lower cost than other molecular tests/NAATs.
Supported by leading institutions and investors
Accurate, fast, and convenient COVID testing
UOL COVID-19 Test utilizes patented molecular chemistry to provide COVID test results with PCR-level accuracy, so you can speed up diagnosis with confidence.
96.1% Accuracy
96.1% Accuracy with no false positives when compared to a highly-sensitive PCR test. Learn more
PCR Sensitivity
NAATs can detect COVID up to 4 days earlier than antigen tests Learn more
Result in 40 minutes
As soon as 12 minutes for positive results.
Negative results in 40 minutes.
5-minute Setup
Anterior nasal swab sample collection, set up and run a test in under 5 minutes.
Powerful Detection
Detect all VOCs including Delta, BA.1, BA.2, BA.4, and BA.5. Analytical sensitivity over 20,000x higher than some commercially-available rapid antigen tests.
Tech Enabled
Our DxPro mobile app automatically interprets data with clear-text results. Patient registration, SMS result delivery, and automated reporting are available*.
*requires additional software integration, contact sales for more info.
EUA Authorized by FDA
The UOL COVID-19 Test has been granted emergency use authorization (EUA) by the FDA for use at the point-of-care setting and is available for purchase by qualified customers with a CLIA ID.
Explore Our Tests
-
UOL COVID-19 Test System
-
UOL COVID-19 Instrument
-
UOL COVID-19 Test Kit
-
DxPro App*
Our Science
Loop-de-Loop™ RT-LAMP
The UOL COVID-19 Test uses a new, patented chemistry, the Loop-de-Loop™ RT-LAMP. Ideal for detection of infectious disease, with the power of PCR without complex equipment.
The result? Lower costs while maintaining accuracy.
Meet the team
We are led by a team of experts in molecular diagnostics and bioengineering and are supported by the National Institute of Health’s Rapid Acceleration of Diagnostics (RADx) initiative and private investors, including Y Combinator. Learn more
Accessible testing for all healthcare providers
New services in pharmacies
Rapid results for primary care
Lower costs at rapid test sites
Schedule a call today
Find out how you can provide the best possible care to your patients while generating more revenue.